Market revenue in 2024 | USD 95.7 million |
Market revenue in 2030 | USD 102.3 million |
Growth rate | 1.1% (CAGR from 2025 to 2030) |
Largest segment | Conventional |
Fastest growing segment | Molecular |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Molecular, Conventional |
Key market players worldwide | BioMerieux SA, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR, Becton Dickinson & Co, Qiagen NV, Thermo Fisher Scientific Inc, Meridian Bioscience, Hologic, Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hospital acquired infections diagnostics market will help companies and investors design strategic landscapes.
Conventional was the largest segment with a revenue share of 54.23% in 2024. Horizon Databook has segmented the Spain hospital acquired infections diagnostics market based on molecular, conventional covering the revenue growth of each sub-segment from 2018 to 2030.
Spain's HAI diagnostics market is characterized by significant growth potential, fueled by an increasing incidence of hospital-acquired infections alongside a robust healthcare infrastructure. The Spanish government has prioritized infection prevention strategies within hospitals, leading to increased awareness about the importance of effective diagnostic tools.
Market forecasts indicate a solid CAGR as hospitals increasingly adopt advanced diagnostic technologies such as enzyme-linked immunosorbent assays (ELISA) and molecular assays. The competitive landscape in Spain features both international players such as Abbott Laboratories and local firms that focus on developing innovative solutions tailored to meet national healthcare needs.
Collaborative efforts between public health entities and private sector companies are essential for advancing HAI diagnostics capabilities. As Spain continues to enhance its healthcare policies regarding infection, the demand for sophisticated diagnostic solutions will likely increase significantly over the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain hospital acquired infections diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Spain hospital acquired infections diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account